Development of innovative strategies for the analysis of bioactive substances.
Development, validation and application of original methods for the quali-quantitative analysis of classical drugs of abuse, new synthetic compounds, doping agents, CNS drugs, metabolites and markers in biological and non-biological samples.
Development of advanced instrumental methods based on high-performance liquid chromatography coupled to several detection means (LC-MS, LC-MS/MS, HPLC-UV/DAD, HPLC-F, HPLC-ED).
Development, optimization and validation of innovative miniaturized sampling and pretreatment procedures for biological and non-biological samples.
Therapeutic drug monitoring (TDM) of CNS drugs: antipsychotics, antidepressants, antiepileptic and sedative-hypnotics.
Analysis of bioactive compounds in natural matrices, food supplements and herbal products.
